Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

MX-68: mechanisms underlying antiinflammatory activity

July 9, 1998

Bone-sparing antiinflammatory benzamide under investigation at Daiichi

July 9, 1998

Vertex/Kissei select development candidate from p38 MAP kinase inhibitor program

July 8, 1998

Long-term safety and efficacy data presented for Enbrel

July 8, 1998

Series of MMP and TACE inhibitors patented by American Cyanamid

July 7, 1998

Boston Life Sciences submits further data supporting Therafectin NDA

July 3, 1998

Additional phase III results reported for Cypress Bioscience's Prosorba Column

July 1, 1998

Celltech scientists discover potent and selective inhibitors of protein kinases

June 26, 1998

HMR discloses preparation and use of series with MMP-inhibitory activity

June 26, 1998

Enbrel BLA accepted for review and assigned priority review status

June 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...